In recent years, psychedelic drugs have become increasingly interesting for treatment of many neuropsychiatric diseases – in particular, the drug psilocybin, which is the psychedelic ingredient in so-called Magic Mushrooms.
In this talk, we will take a trip into the biological and pharmacological basis of psilocybin, and get a step closer to what we know about this drug and its workings in the brain and body.
We’ll answer the central questions of what psilocybin even is, what the biological targets and effects are and explain the resent trend of microdosing.
But we’ll also address some of the more difficult questions: How can a single dose of drug have long lasting effects on mood and behavior? Is the psychedelic experience a central element in the proposed treatment effects? Are there any ethical concerns?
And even if it works – what are the risks?
Mikael Palner is an associate professor at the Department of Clinical Research at the University of Southern Denmark, and researcher at the Neurobiology Research Unit at Rigshospitalet. The lecture is set up in collaboration with Forskningens Døgn.
Practical info: Participation in the event is free, although we ask a voluntary donation to help cover the venue cost.
The venue is Studenterhuset in Copenhagen, close by Rundetårn. The café is open all evening.